Clinical trial
Cell Repair in Heart Failure
NCT00285454 · Imperial College London, Other · Withdrawn
Key facts
| NCT number | NCT00285454 |
|---|---|
| Title | Cell Repair in Heart Failure |
| Official title | A Phase I/II, Randomised, Double-blind, Placebo Controlled, Single-centre Study of Bone Marrow Mononuclear Cells by Percutaneous Retrograde Coronary Venous Delivery to Patients With Ischaemic Heart Failure and no Standard Revascularisation Options. |
| Lead sponsor | Imperial College London, Other |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Heart Failure, Ischemia |
| Intervention type | Procedure |
| Interventions | Retrograde coronary venous delivery of cells. |
| Enrollment | 0 |
| Start date | Jan 1, 2006 |
| Primary completion | Feb 1, 2006 |
| Completion | Dec 1, 2008 |
| First posted | Feb 2, 2006 |
| Last update posted | Mar 31, 2015 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: